ARCS-Based Training to Improve Nursing Students' Communication, Motivation, and Self-Efficacy (ARCS-NCOMSE)

June 16, 2025 updated by: Hulya Kocyigit, Cumhuriyet University

The Effect of Training Based on the ARCS Motivation Model on Nursing Students' Communication Skills, Learning Motivation, and Self-Efficacy: A Randomized Controlled Trial

This study explores the impact of an ARCS-based training program on nursing students' communication skills, learning motivation, and self-efficacy. Communication is essential in nursing for quality patient care and safety, yet students often struggle with it. The ARCS Motivation Model-focused on Attention, Relevance, Confidence, and Satisfaction-aims to boost motivation and improve learning outcomes. Using a randomized controlled design, the study compares an experimental group receiving ARCS-based training with a control group receiving traditional education. Key outcomes include improved communication skills, motivation, and self-efficacy. This research highlights the potential of the ARCS model in enhancing nursing education and student performance.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study aims to examine the impact of an education program based on the ARCS Motivation Model on nursing students' communication skills, learning motivation, and self-efficacy levels. The nursing profession requires not only clinical knowledge and technical skills but also effective communication abilities, as communication plays a crucial role in enhancing patient care quality and ensuring patient safety. However, research has shown that nursing students often face deficiencies in their communication skills, which can negatively affect their professional development. Consequently, there is an increasing need for learner-centered and motivating educational approaches.

The ARCS Motivation Model, consisting of four key components-Attention, Relevance, Confidence, and Satisfaction-aims to enhance learning motivation. Literature suggests that this model positively impacts nursing students' learning processes. This study investigates whether ARCS-based training is effective in improving nursing students' communication skills, learning motivation, and self-efficacy.

The research will be conducted using a randomized controlled design with first-year nursing students from Tokat Gaziosmanpaşa University. The students will be randomly assigned to either an experimental or a control group. The experimental group will receive ARCS-based education, while the control group will receive traditional education. The study will evaluate whether there are significant differences in communication skills, learning motivation, and self-efficacy between the two groups at the end of the training process.

Data will be collected using the Effective Communication Skills Scale, Learning Motivation Scale, Self-Efficacy Scale, and a Demographic Information Form. These instruments will measure the participants' communication skills, motivation levels, and demographic characteristics. The ARCS model's four stages (Attention, Relevance, Confidence, and Satisfaction) will be applied through teaching materials and group activities during the intervention.

In conclusion, this study aims to explore the effects of an ARCS-based training model in improving nursing students' communication skills and motivation, providing insights into the effectiveness of motivation-enhancing educational methods.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
60

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Turkey
      • Tokat, Turkey, 60000
        • Recruiting
        • Tokat Gaziosmanpaşa Universty
        • Contact:
        • Principal Investigator:
          • Hülya KOÇYİĞİT KAVAK, Phd
        • Sub-Investigator:
          • Şeyda Kazanç, Phd

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  • Must be enrolled in the 1st year of the Nursing Faculty
  • Must be participating in clinical practice (internship) for the first time
  • Must voluntarily agree to participate in the study and sign the informed consent form
  • Must agree to attend all designated sessions during the training period
  • Must have proficiency in reading and writing Turkish
  • Must have a suitable health condition for participation in individual and group activities

Exclusion Criteria:

Has previously participated in any clinical practice/internship

  • Has previously attended specialized training on communication skills, self-efficacy, or learning motivation
  • Unable to attend 2 or more sessions during the research process
  • Decides to withdraw from participation during the research or withdraws consent
  • Provides incomplete or incorrect responses to data (significant omissions in pre-test or post-test forms)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: ARCS (Attention, Relevance, Confidence, Satisfaction) motivation model
ARCS (Attention, Relevance, Confidence, Satisfaction) motivation model-based training program on nursing students
Other: The ARCS Motivation Model Education
The ARCS Motivation Model Education-focused on Attention, Relevance, Confidence, and Satisfaction
No Intervention: Traditional Education
communication skills Traditional Education

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
communication skills
Time Frame: 1 week before and 2 weeks after the intervention
Communication Skills Measured by: Effective Communication Skills Scale (Range: 34-170; higher scores indicate better communication skills)
1 week before and 2 weeks after the intervention
learning motivation
Time Frame: 1 week before and 2 weeks after the intervention
MotivationMeasured by: Motivation Scale Related to Instructional Material (Range: 33-165; higher scores indicate better learning motivation)
1 week before and 2 weeks after the intervention
self-efficacy levels
Time Frame: 1 week before and 2 weeks after the intervention
Self-efficacy Measured by: Academic Self-Efficacy Scale (Range: 33-165; higher scores indicate better self-efficacy)
1 week before and 2 weeks after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Cumhuriyet University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 26, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 10, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 20, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 12, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 3, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 4, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 19, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 16, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Scü-Gop

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

I would like to share it after the research is completed.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Educational Intervention

Clinical Trials on The ARCS Motivation Model Education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings